News 2016 | Strand Life Sciences

Strand Life Sciences expands onco-genomic portfolio in India with the globally benchmarked 152-gene StrandAdvantage test

https://strandls.com/wp-content/themes/osmosis/images/empty/thumbnail.jpg 150 150 Strand Life Sciences Strand Life Sciences https://secure.gravatar.com/avatar/a6ea35408ed49604a9b4794bbe46001b?s=96&d=mm&r=g December 20, 2016 May 23, 2017

By: Strand Life Sciences

December 20, 2016

December 20, 2016 | Bangalore, India It is vital for oncologists to get clinically actionable and timely results to decide on treatment options for…

New NGS-based approach scores high in diagnosing Retinoblastoma: Study

By: Strand Life Sciences

November 9, 2016

Approach proves to be six times more economical than Reflex Mode Testing November 09, 2016 | Bangalore, India Strand Life Sciences, a genomic profiling…

Strand Chief Technology Officer Dr. Ramesh Hariharan elected as a Fellow of the prestigious Indian Academy of Sciences (IASc)

By: Strand Life Sciences

April 21, 2016

Congratulations to our Chief Technology Officer Dr. Ramesh Hariharan on his election as a Fellow of the prestigious Indian Academy of Sciences (IASc). As…

Strand Life Sciences Announces Key Publication Demonstrating Clinical Utility of its Germline Cancer Multi-gene Test for Hereditary Breast and Ovarian Cancer (HBOC)

By: Strand Life Sciences

March 3, 2016

Strand Life Sciences, a global leader in precision medicine diagnostics announced the publication of a landmark study in the Journal of Human Genetics in…

Strand Life Sciences NGS Laboratory First in India to Receive Both CAP and NABL Accreditations

By: Strand Life Sciences

February 25, 2016

Strand Life Sciences, a global genomic profiling company aimed at empowering personalized cancer care and genetic testing for inherited diseases, announced that its Next-Generation…